Pricing

Pardes Biosciences Inc (PRDS)

followers ·
Sector:
FINANCE
Industry:
GENERAL FINANCE
CEO:
Thomas G. Wiggans
Employees:
30
2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD, CA, 92008
415-649-8758
    Formally known as:
  • FS Development Corp II

Are you looking for this stock instead?

Pardes Biosciences, Inc. focuses on discovering, developing, and commercializing novel therapeutics. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome coronavirus 2 infections and associated diseases.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available